Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2017 Filed Jun 1, 2017 20:20 UTC |
TELLEZ CORA MDirector
|
PurchaseCommon Stock | 7,550 | $0.42 | $3,133.25 |
DisclosureSEC source: 0001354488-17-000570 · issuerdirect_section16.xml · nonDerivative · entry 1 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,371 F1 · shares: The purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 19, 2016. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:05 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 75,000 | $0.48 | $35,625.00 |
DisclosureSEC source: 0001354488-17-000530 · issuerdirect_section16.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:21 UTC |
TELLEZ CORA MDirector
|
PurchaseCommon Stock | 50,000 | $0.48 | $24,000.00 |
DisclosureSEC source: 0001354488-17-000518 · issuerdirect_section16.xml · nonDerivative · entry 1 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,821 Read SEC document |
| May 15, 2017 Filed May 17, 2017 16:08 UTC |
Kaplan MyronDirector
|
PurchaseCommon Stock | 30,000 | $0.49 | $14,820.00 |
DisclosureSEC source: 0001354488-17-000517 · issuerdirect_section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.472 to $0.500. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 15, 2017 Filed May 17, 2017 16:05 UTC |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 15,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000512 · issuerdirect_section16.xml · derivative · entry 12 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,306 Underlying: Common Stock · 15,306 shares Expires not disclosed F4 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F4 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F4 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| May 15, 2017 Filed May 17, 2017 16:05 UTC |
Dillione JanetDirector
|
PurchaseCommon Stock | 21,231 | $0.48 | $10,084.73 |
DisclosureSEC source: 0001354488-17-000512 · issuerdirect_section16.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,969 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.473 to $0.475. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:21 UTC |
TELLEZ CORA MDirector
|
GrantPhantom Stock · Derivative | 15,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000518 · issuerdirect_section16.xml · derivative · entry 17 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,306 Underlying: Common Stock · 15,306 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F3 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F3 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:08 UTC |
Markvicka TauniaDirector
|
PurchaseCommon Stock | 14,500 | $0.51 | $7,395.00 |
DisclosureSEC source: 0001354488-17-000516 · issuerdirect_section16.xml · nonDerivative · entry 1 Markvicka Taunia · CIK 0001545282 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,100 Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:06 UTC |
Cook Robert W.Chief Financial Officer
|
PurchaseCommon Stock | 50,000 | $0.50 | $24,950.00 |
DisclosureSEC source: 0001354488-17-000513 · issuerdirect_section16.xml · nonDerivative · entry 1 Cook Robert W. · CIK 0001235438 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:07 UTC |
GEORGE MICHAEL WDirector
|
GrantPhantom Stock · Derivative | 15,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000514 · issuerdirect_section16.xml · derivative · entry 17 GEORGE MICHAEL W · CIK 0001190102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,306 Underlying: Common Stock · 15,306 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F3 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F3 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:07 UTC |
GEORGE MICHAEL WDirector
|
PurchaseCommon Stock | 10,000 | $0.50 | $4,990.00 |
DisclosureSEC source: 0001354488-17-000514 · issuerdirect_section16.xml · nonDerivative · entry 1 GEORGE MICHAEL W · CIK 0001190102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:06 UTC |
TELLEZ CORA MDirector
|
PurchaseCommon Stock | 4,800 | $0.66 | $3,156.00 |
DisclosureSEC source: 0001354488-17-000471 · issuerdirect_section16.xml · nonDerivative · entry 1 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,821 F1 · shares: The purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 19, 2016. Read SEC document |
| March 30, 2017 Filed Mar 31, 2017 20:01 UTC |
TELLEZ CORA MDirector
|
PurchaseCommon Stock | 1,950 | $1.66 | $3,237.00 |
DisclosureSEC source: 0001354488-17-000450 · issuerdirect_section16.xml · nonDerivative · entry 1 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,021 F1 · shares: The purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 19, 2016. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:01 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 100,000 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001354488-17-000385 · issuerdirect_section16.xml · derivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-03-01 F1 · shares: The option vests based on certain performance milestones, subject to continued employment. The option will be forfeited if such milestones are not met by certain dates. F1 · derivative.exercise_date: The option vests based on certain performance milestones, subject to continued employment. The option will be forfeited if such milestones are not met by certain dates. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 21:01 UTC |
TELLEZ CORA MDirector
|
PurchaseCommon Stock | 1,540 | $2.10 | $3,230.77 |
DisclosureSEC source: 0001354488-17-000350 · issuerdirect_section16.xml · nonDerivative · entry 1 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,071 F1 · shares: The purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 19, 2016. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 16:06 UTC |
Kaplan MyronDirector
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000310 · issuerdirect_section16.xml · derivative · entry 3 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 16:06 UTC |
Kaplan MyronDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001354488-17-000310 · issuerdirect_section16.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-02-21 F1 · derivative.exercise_date: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 16:05 UTC |
Dillione JanetDirector
|
GrantRestricted Stock Units · Derivative | 15,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000308 · issuerdirect_section16.xml · derivative · entry 3 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,357 Underlying: Common Stock · 15,357 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.underlying_shares: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 16:05 UTC |
Dillione JanetDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001354488-17-000308 · issuerdirect_section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-02-21 F1 · derivative.exercise_date: The options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:07 UTC |
TELLEZ CORA MDirector
|
GrantRestricted Stock Units · Derivative | 20,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000312 · issuerdirect_section16.xml · derivative · entry 3 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,714 Underlying: Common Stock · 20,714 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:07 UTC |
TELLEZ CORA MDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001354488-17-000312 · issuerdirect_section16.xml · derivative · entry 2 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-02-21 F1 · derivative.exercise_date: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:07 UTC |
Markvicka TauniaDirector
|
GrantRestricted Stock Units · Derivative | 13,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000311 · issuerdirect_section16.xml · derivative · entry 3 Markvicka Taunia · CIK 0001545282 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,571 Underlying: Common Stock · 13,571 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:07 UTC |
Markvicka TauniaDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001354488-17-000311 · issuerdirect_section16.xml · derivative · entry 2 Markvicka Taunia · CIK 0001545282 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-02-21 F1 · derivative.exercise_date: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:06 UTC |
GEORGE MICHAEL WDirector
|
GrantRestricted Stock Units · Derivative | 12,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000309 · issuerdirect_section16.xml · derivative · entry 2 GEORGE MICHAEL W · CIK 0001190102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,232 Underlying: Common Stock · 12,232 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:06 UTC |
GEORGE MICHAEL WDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001354488-17-000309 · issuerdirect_section16.xml · derivative · entry 1 GEORGE MICHAEL W · CIK 0001190102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-02-21 F1 · derivative.exercise_date: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 16:01 UTC |
Dillione JanetDirector
|
PurchasePhantom Stock · Derivative | 3,472 | $7,500.00 Strike: $0.00 | $26,040,000.00 |
DisclosureSEC source: 0001354488-17-000266 · issuerdirect_section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,472 Underlying: Common Stock · 3,472 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · shares: These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation for directors' fees. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:02 UTC |
GEORGE MICHAEL WDirector
|
PurchasePhantom Stock · Derivative | 3,472 | $7,500.00 Strike: $0.00 | $26,040,000.00 |
DisclosureSEC source: 0001354488-17-000268 · issuerdirect_section16.xml · derivative · entry 1 GEORGE MICHAEL W · CIK 0001190102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,472 Underlying: Common Stock · 3,472 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · shares: These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of directors' fees. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:01 UTC |
TELLEZ CORA MDirector
|
PurchasePhantom Stock · Derivative | 3,472 | $7,500.00 Strike: $0.00 | $26,040,000.00 |
DisclosureSEC source: 0001354488-17-000267 · issuerdirect_section16.xml · derivative · entry 2 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,472 Underlying: Common Stock · 3,472 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · shares: These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation for directors' fees. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| February 07, 2017 Filed Feb 8, 2017 21:01 UTC |
Pfaffle AntonyChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001354488-17-000231 · issuerdirect_section16.xml · derivative · entry 3 Pfaffle Antony · CIK 0001368953 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock, $0.001 par value per share · 10,000 shares Expires 2022-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on September 19, 2016. F2 · derivative.exercise_date: These options vested as follows: fifty percent (50%) on the date of issuance of the CE mark certification, which occurred on July 5, 2013, and (b) fifty percent (50%) on December 31, 2013. Read SEC document |
| February 07, 2017 Filed Feb 8, 2017 21:01 UTC |
Pfaffle AntonyChief Scientific Officer
|
SaleCommon Stock | 10,000 | $2.00 | $20,000.00 |
DisclosureSEC source: 0001354488-17-000231 · issuerdirect_section16.xml · nonDerivative · entry 2 Pfaffle Antony · CIK 0001368953 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on September 19, 2016. Read SEC document |
| February 07, 2017 Filed Feb 8, 2017 21:01 UTC |
Pfaffle AntonyChief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.68 | $6,800.00 |
DisclosureSEC source: 0001354488-17-000231 · issuerdirect_section16.xml · nonDerivative · entry 1 Pfaffle Antony · CIK 0001368953 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 22:39 UTC |
TELLEZ CORA MDirector
|
PurchaseCommon Stock | 1,780 | $1.79 | $3,183.17 |
DisclosureSEC source: 0001354488-17-000193 · issuerdirect_section16.xml · nonDerivative · entry 1 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,531 F1 · shares: The purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 19, 2016. Read SEC document |
| January 30, 2017 Filed Feb 9, 2017 21:30 UTC |
Abrams Judith RChief Medical Officer
|
GrantStock Option (Right to buy Common Stock) · Derivative | 185,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0001354488-17-000245 · issuerdirect_section16.xml · derivative · entry 2 Abrams Judith R · CIK 0001697499 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2027-01-30 F1 · date: The option was granted on 1/30/17 contingent upon the Reporting Person commencing employment on 2/1/17. F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on the first anniversary of the vesting commencement date, 2/1/18, subject to continued employment. Read SEC document |
| January 30, 2017 Filed Feb 9, 2017 21:30 UTC |
Abrams Judith RChief Medical Officer
|
GrantStock Option (Right to buy Common Stock) · Derivative | 165,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0001354488-17-000245 · issuerdirect_section16.xml · derivative · entry 1 Abrams Judith R · CIK 0001697499 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,000 Underlying: Common Stock · 165,000 shares Expires 2027-01-30 F1 · date: The option was granted on 1/30/17 contingent upon the Reporting Person commencing employment on 2/1/17. F2 · derivative.exercise_date: The option vests based on certain performance milestones. The option will be forfeited if such milestones are not met by certain dates. Read SEC document |
| January 30, 2017 Filed Feb 9, 2017 21:28 UTC |
Cook Robert W.Chief Financial Officer
|
GrantStock Option (Right to buy Common Stock) · Derivative | 185,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0001354488-17-000243 · issuerdirect_section16.xml · derivative · entry 2 Cook Robert W. · CIK 0001235438 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2027-01-30 F1 · date: The option was granted on 1/30/17 contingent upon the Reporting Person commencing employment on 2/1/17. F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on the first anniversary of the vesting commencement date, 2/1/18, subject to continued employment. Read SEC document |
| January 30, 2017 Filed Feb 9, 2017 21:28 UTC |
Cook Robert W.Chief Financial Officer
|
GrantStock Option (Right to buy Common Stock) · Derivative | 165,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0001354488-17-000243 · issuerdirect_section16.xml · derivative · entry 1 Cook Robert W. · CIK 0001235438 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,000 Underlying: Common Stock · 165,000 shares Expires 2027-01-30 F1 · date: The option was granted on 1/30/17 contingent upon the Reporting Person commencing employment on 2/1/17. F2 · derivative.exercise_date: The option vests based on certain performance milestones. The option will be forfeited if such milestones are not met by certain dates. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 21:01 UTC |
TELLEZ CORA MDirector
|
PurchaseCommon Stock | 1,990 | $1.58 | $3,144.20 |
DisclosureSEC source: 0001354488-17-000009 · issuerdirect_section16.xml · nonDerivative · entry 1 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,751 F1 · shares: The purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 19, 2016. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:01 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 10,000 | $1.77 | $17,700.00 |
DisclosureSEC source: 0001354488-16-008655 · issuerdirect_section16.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 21:24 UTC |
TELLEZ CORA MDirector
|
PurchaseCommon Stock | 1,800 | $1.80 | $3,240.00 |
DisclosureSEC source: 0001354488-16-008619 · issuerdirect_section16.xml · nonDerivative · entry 1 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,761 F1 · shares: This purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 19, 2016. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 16:05 UTC |
Dillione JanetDirector
|
PurchasePhantom Stock · Derivative | 4,143 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001354488-16-008518 · issuerdirect_section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,143 Underlying: Common Stock · 4,143 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · shares: These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation for directors' fees. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 21:07 UTC |
GEORGE MICHAEL WDirector
|
PurchasePhantom Stock · Derivative | 4,143 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001354488-16-008520 · issuerdirect_section16.xml · derivative · entry 1 GEORGE MICHAEL W · CIK 0001190102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,143 Underlying: Common Stock · 4,143 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · shares: These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of directors' fees. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 21:05 UTC |
TELLEZ CORA MDirector
|
PurchaseCommon Stock · Derivative | 4,143 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001354488-16-008519 · issuerdirect_section16.xml · derivative · entry 2 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,143 Underlying: Common Stock · 4,143 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · shares: These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation for directors' fees. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 20:01 UTC |
TELLEZ CORA MDirector
|
PurchaseCommon Stock | 1,475 | $2.15 | $3,171.25 |
DisclosureSEC source: 0001638599-16-001480 · doc4_4274.xml · nonDerivative · entry 1 TELLEZ CORA M · CIK 0001189703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,961 F1 · shares: This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 19, 2016. Read SEC document |
| October 21, 2016 Filed Oct 25, 2016 20:32 UTC |
Pfaffle AntonyDirector · Chief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001354488-16-008420 · issuerdirect_section16.xml · derivative · entry 3 Pfaffle Antony · CIK 0001368953 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock, $0.001 par value per share · 20,000 shares Expires 2022-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on September 19, 2016. F3 · derivative.exercise_date: These options vested as follows: (a) fifty percent (50%) on the date of the issuance of the CE mark certification, which occurred on July 5th, 2013, and (b) fifty percent (50%) on December 31, 2013. Read SEC document |
| October 21, 2016 Filed Oct 25, 2016 20:32 UTC |
Pfaffle AntonyDirector · Chief Scientific Officer
|
SaleCommon Stock, $0.001 par value per share | 20,000 | $2.23 | $44,600.00 |
DisclosureSEC source: 0001354488-16-008420 · issuerdirect_section16.xml · nonDerivative · entry 2 Pfaffle Antony · CIK 0001368953 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on September 19, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.226 to $2.228, inclusive. Read SEC document |
| October 21, 2016 Filed Oct 25, 2016 20:32 UTC |
Pfaffle AntonyDirector · Chief Scientific Officer
|
Exercise / conversionCommon Stock, $0.001 par value per share | 20,000 | $0.68 | $13,600.00 |
DisclosureSEC source: 0001354488-16-008420 · issuerdirect_section16.xml · nonDerivative · entry 1 Pfaffle Antony · CIK 0001368953 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:50 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001354488-16-008364 · issuerdirect_section16.xml · derivative · entry 3 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2026-10-03 F3 · derivative.exercise_date: The option vests based on certain performance milestones. If such milestones are met prior to 12/31/18, then the option will not vest until 12/31/18. The option will be forfeited if such milestones are not met by 10/3/2020. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:50 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001354488-16-008364 · issuerdirect_section16.xml · derivative · entry 2 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2026-10-03 F2 · derivative.exercise_date: The option vests on the date the Company?s common stock attains an average closing price over any period of 30 consecutive trading days equal to or greater than 2.75 times the closing price per share on the lesser of 9/23/16 or 10/3/16 (the ?Stock Price Condition"); provided, that if the Stock Price Condition is met prior to 12/31/18 then the option will not vest until 12/31/18. The option will be forfeited (i) if the stock price on 12/31/18 is below the closing price per share on the lesser of 9/23/16 or 10/3/16, or (ii) if the Stock Price Condition is not met by 10/3/2020. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:50 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 1,250,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001354488-16-008364 · issuerdirect_section16.xml · derivative · entry 1 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 1,250,000 shares Expires 2026-10-03 F1 · derivative.exercise_date: The option vests as follows: 25% on 10/3/2017, 25% on 10/3/2018, 25% on 10/3/2019, and 25% on 10/3/2020. Read SEC document |
| October 03, 2016 Filed Oct 11, 2016 14:37 UTC Amendment |
Baluch KhosoDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001354488-16-008375 · issuerdirect_section16.xml · derivative · entry 3 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2026-09-30 F3 · derivative.exercise_date: The option vests based on certain performance milestones. If such milestones are met prior to 12/31/18, then the option will not vest until 12/31/18. The option will be forfeited if such milestones are not met by 10/3/2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.